TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
ELEVAI Labs Inc. ( (ELAB) ) has issued an update.
On August 22, 2025, PMGC Holdings Inc. entered into a warrant inducement agreement with certain warrant holders, reducing the exercise price of existing warrants and issuing new unregistered warrants. The transactions, completed on August 25, 2025, generated gross proceeds of $1,668,218.50 for the company, with Univest Securities, LLC acting as the exclusive warrant inducement agent, receiving a fee of $146,775.30.
Spark’s Take on ELAB Stock
According to Spark, TipRanks’ AI Analyst, ELAB is a Underperform.
ELEVAI Labs Inc. is rated poorly due to major financial weaknesses, including negative revenue and cash flow issues, which are exacerbated by adverse technical indicators. The lack of favorable valuation metrics further weighs down the stock’s score. The absence of applicable corporate events means no positive catalysts are present to offset these challenges.
To see Spark’s full report on ELAB stock, click here.
More about ELEVAI Labs Inc.
Average Trading Volume: 3,120,128
Technical Sentiment Signal: Sell
Current Market Cap: $3.52M
See more data about ELAB stock on TipRanks’ Stock Analysis page.